Project Details
Description
An Open-label, Proof of Concept Study of Gevokizumab in the Treatment of the Acute, Inflammatory Phase of Pyoderma Gangrenosum
| Status | Finished |
|---|---|
| Effective start/end date | 6/15/13 → 6/15/14 |
Funding
- XOMA CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.